Does Dr. DAMIEN ABREU have financial conflicts of interest?

Dr. DAMIEN ABREU (MD, PHD) has received a total of $4,492 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $4,492 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DAMIEN ABREU?

According to CMS Open Payments data, Dr. DAMIEN ABREU received funding from ABBVIE ($1,200), ALLERGAN ($955), and E.R. SQUIBB & SONS, L.L.C ($548).

Does Dr. DAMIEN ABREU receive research grants or speaking fees?

Dr. DAMIEN ABREU has received $4,492 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DAMIEN ABREU

MD, PHDReal-Time Hydrated

Specialty: Student in an Organized Health Care Education/Training Program

Practice Location: BALTIMORE, MD 21287

NPI Number: 1083286512

LIFETIME INDUSTRY VALUE

$4,492

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABREU is a verified Student in an Organized Health Care Education/Training Program practitioner based in BALTIMORE, MD.

Between 2021 and 2024, Dr. ABREU had an overall industry promotional and research financial footprint of $4,492 as recorded in the federal CMS Open Payments database.

$4,492 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABREU's primary funding source is ABBVIE, which accounts for $1,200 (representing 26.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$1,200

26.7%

ALLERGAN

Rank 2

$955

21.3%

E.R. SQUIBB & SONS, L.L.C

Rank 3

$548

12.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.